Additionally, AD-associated aggregation of Tau loses its ability to bind to DNA [35,36]; thus, it has been postulated that the loss of Tau from the nucleus could contribute to the accumulation of DNA damage as observed in AD patient brains. The gene discussed is MAPT; the disease is Alzheimer disease.